Академический Документы
Профессиональный Документы
Культура Документы
E
piglottitis is an infection of the supraglottic larynx
agement takes precedence over all
(portion of the larynx superior to the vocal folds). It is
other interventions and requires a potentially lethal condition if not recognized and
multidisciplinary coordination be- treated promptly. Prior to the introduction of the
tween emergency medicine, an- conjugated Haemophilus influenzae type b (Hib) vaccine, epiglottitis
esthesiology, and otolaryngology primarily affected children from 2 to 6 years of age. Since the
providers. An immediate diagnosis, introduction of the vaccine, there has been a decline in pediatric
treatment, and prophylaxis for close cases and an increase in adult supraglottitis, particularly those
contacts greatly improve recovery between 45-64 years and older than 85 years. 1 Although there
time, increase survival rate, and, in has been a relative decrease in the incidence of disease,
turn, reduce overall cost of disease epiglottitis should still be considered in the differential diagnosis
management and patient care. The of any child who presents with acute upper airway obstruction.
This article will review the current microbiology, presentation,
potential lethality of this disease
evaluation, management, and prevention techniques of pediatric
mandates that all health care pro-
epiglottitis.
viders remain acutely aware of how
to immediately and effectively
triage and intervene with a patient
MICROBIOLOGY
with epiglottitis.
H influenzae type b was a significant source of pediatric
morbidity and mortality prior to the 1990s. This gram-negative
Keywords: aerobic coccobacillus was the causative organism for most cases
bacteremia; bacterial infection;
of epiglottitis, meningitis, and other serious bacterial infections
children; epiglottitis; H influenzae in children. The Hib vaccine was introduced in the United States
type b; inflammation; laryngeal/ in 1985 as a polysaccharide vaccine. Polysaccharides result in T
airway obstruction; pediatric; cell–independent B-cell activation, which results in poor or
supraglottitis; swelling; vaccine absent immune response in infants who have an immature
immune system. 2 The polysaccharide component was later
attached to a protein carrier to improve the efficacy of the
*Department of Otolaryngology and vaccine by recruiting T cells to the immune response. The
Communication Enhancement, Boston conjugate vaccine is now recommended by the Centers for
Children's Hospital, Boston, MA;
Disease Control and Prevention for all US children younger
†Department of Otology and Laryngology,
than 5 years. It is typically administered initially at 2 months
Harvard Medical School, Boston, MA;
‡Division of Otolaryngology, Children's of age and is available in combination with other vaccines
National Medical Center, Washington, DC. such as diphtheria, tetanus, and pertussis to limit the number
Reprint requests and correspondence: of injections.
Rahul Shah, MD, FACS, Division of Despite widespread use of the Hib vaccine, vaccine failure is possible
Otolaryngology, Children's National Medical and cases of Hib epiglottitis are still reported. 3–7Streptococcus
Epiglottitis Rapid onset, high fever, inspiratory stridor, “Thumb print,” thickened aryepiglottic folds,
toxic appearance, drooling, tripod position hypopharyngeal distension
Laryngotracheobronchitis (croup) Viral prodrome, hoarseness, stridor, barking cough “Steeple” sign
Peritonsillar abscess Trismus, drooling, muffled voice quality N/A
Retropharyngeal/parapharyngeal Fever, trismus, neck swelling, decreased Retropharyngeal thickening
abscess neck range of motion, drooling
Bacterial tracheitis Rapid onset, fever, cough, stridor, toxic appearance Tracheal haziness
152 VOL. 16, NO. 3 • EPIGLOTTITIS / ADIL ET AL.
PREVENTION
The rate of secondary disease in the 60 days after
exposure to a patient infected with Hib is highest for
patients younger than 12 months (6%). 15 For
household contacts younger than 48 months, the
rate drops to 2.1%. The risk for household contacts
is highest; information regarding day care contacts
Figure 3. Edematous, erythematous epiglottis as seen during
direct laryngoscopy in a patient previously intubated for epiglottitis. is conflicting. Regardless of immunization status,
Courtesy of Joshua Nagler, MD, MHPEd. chemoprophylaxis with rifampin is recommended
for household contacts that are young (b 4 years
EPIGLOTTITIS / ADIL ET AL. • VOL. 16, NO. 3 153
of age) or immunocompromised (b 18 years of age). 10 4. Gonzalez Valdepena H, Wald ER, Rose E, et al. Epiglottitis and
Chemoprophylaxis is recommended for all children Haemophilus influenza immunization: the Pittsburgh experience—
and providers at a child care facility if there have been a five-year review. Pediatrics 1995;96:424–7.
more than 2 cases of invasive Hib infection in the prior 5. Gorelick MH, Baker MD. Epiglottitis in children, 1979
through 1992. Effects of Haemophilus influenzae type b
60-day period and if there are unimmunized or
immunization. Arch Pediatr Adolesc Med 1994;148:47–50.
underimmunized children who attend the facility. 6. Faden H. The dramatic change in the epidemiology of
pediatric epiglottitis. Pediatr Emerg Care 2006;22:443–4.
7. Isaacson G, Isaacson DM. Pediatric epiglottitis caused by
SUMMARY group G beta-hemolytic Streptococcus. Pediatr Infect Dis J
Acute pediatric epiglottitis is rare since the 2003;22:846–7.
8. Rosbe K, Kenna MA, Roberson D. Atypical epiglottitis. Arch
introduction of the conjugated Hib vaccine. A recent
Otolaryngol Head Neck Surg 2000;126:1153,57–8.
study using a national inpatient database found only 9. Verghese ST, Hannallah RS. Pediatric otolaryngologic
342 pediatric admissions for epiglottitis in the emergencies. Anesthesiol Clin North America 2001;19:
United States in 2003. 16 Of these patients, 40 237–56.
required an airway intervention such as intubation 10. American Academy of Pediatrics. Haemophilus influenzae
infections. In: Pickering L, Baker C, Kimberlin D, Long S,
or tracheostomy. Given the rarity of this condition
editors. Red book: 2012 report of the Committee on
and its potential morbidity, clinicians must main- Infectious Diseases. Elk Grove Village, IL: American Acad-
tain a high index of suspicion when approaching any emy of Pediatrics; 2012. p. 345–52.
child with acute upper airway obstruction. If there is 11. Shapiro ED, Wald ER. Efficacy of rifampin in eliminating
concern for acute epiglottitis based on rapid onset of pharyngeal carriage of Haemophilus influenzae type b. Pediat-
rics 1980;66:5–8.
symptoms, inspiratory stridor, and toxic appear-
12. McCracken G, Ginsburg CM, Zweighaft TC, Clahsen J.
ance, then invasive assessments should be avoided Pharmacokinetics of rifampin in infants and children:
and immediate consultation with anesthesiology relevance to prophylaxis against Haemophilus influenzae type
and otolaryngology should be a priority. b disease. Pediatrics 1980;66:17–21.
13. Glode M, Daum R, Boies E, et al. Effect of rifampin
chemoprophylaxis on carriage eradication and new acquisi-
REFERENCES tion of Haemophilus influenzae type b in contacts. Pediatrics
1985;76:537–42.
1. Shah RK, Stocks C. Epiglottitis in the United States: national 14. Band J, Faser D, Ajello G. Prevention of Haemophilus influenzae
trends, variances, prognosis, and management. Laryngo- type b disease. JAMA 1984;251:2381–6.
scope 2010;120:1256–62. 15. Wenger JD, Ward JI. Haemophilus influenzae vaccine. In:
2. Kelly DF, Moxon ER, Pollard AJ. Haemophilus influenza type b Plotkin SA, Orenstein WA, Offit PA, editors. Vaccines. 4th ed.
conjugate vaccines. Immunology 2004;113:163–74. Philadelphia, PA: WB Saunders Company; 2003. p. 229–68.
3. Shah RK, Roberson DW, Jones DT. Epiglottitis in the 16. Acevedo JL, Lander L, Choi S, Shah RK. Airway management
Hemophilus influenza type b vaccine era: changing trends. in pediatric epiglottitis: a national perspective. Otolaryngol
Laryngoscope 2004;114:557–60. Head Neck Surg 2009;140:548–51.